136 related articles for article (PubMed ID: 26303768)
1. Induction of protective and therapeutic anti-cancer immunity by using bispecific anti-idiotype antibody G22-I50 for nasopharyngeal carcinoma.
Wang JJ; Liu YH; Li GC
Int Immunopharmacol; 2015 Oct; 28(2):1026-33. PubMed ID: 26303768
[TBL] [Abstract][Full Text] [Related]
2. The ability of human bispecific anti-idiotype antibody to elicit humoral and cellular immune responses in mice.
Wang JJ; Li YH; Liu YH; Song J; Guo FJ; Li YL; Li GC
Int Immunopharmacol; 2010 Jun; 10(6):707-12. PubMed ID: 20382274
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effects of tumor-derived heat shock protein in DNA vaccination against nasopharyngeal carcinoma.
Wang JJ; Luo C; Li YH; Li GC
Int Immunopharmacol; 2011 Apr; 11(4):462-7. PubMed ID: 21220058
[TBL] [Abstract][Full Text] [Related]
4. In vitro anti-tumor immune mechanism of nasopharyngeal carcinoma bispecific anti-idiotype antibody.
Wang J; Li Y; Li Y; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 35(8):777-83. PubMed ID: 20818068
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and efficacy of a DNA vaccine encoding a human anti-idiotype single chain antibody against nasopharyngeal carcinoma.
Luo C; Wang JJ; Li YH; Hu JY; Li GC
Vaccine; 2010 Mar; 28(15):2769-74. PubMed ID: 20117260
[TBL] [Abstract][Full Text] [Related]
6. Expression and activity identification of a human nasopharyngeal carcinoma I50 anti-idiotype antibody.
Wang J; Li Y; Guo F; Zhou G; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 36(3):185-91. PubMed ID: 21464538
[TBL] [Abstract][Full Text] [Related]
7. [Construction of eukaryotic expression vector encoding human nasopharyngeal carcinoma anti-idiotype antibody single chain fragment gene G22 and its expression].
Luo C; He XJ; Zhao Y; Zhang ZJ; Li GC
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):16-20. PubMed ID: 18245898
[TBL] [Abstract][Full Text] [Related]
8. [Preparation of human nasopharyngeal carcinoma bivalent anti-idiotype antibody vaccine and identification of its activity].
Wang JJ; Guo FJ; Li YH; Li GC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):667-70. PubMed ID: 20619091
[TBL] [Abstract][Full Text] [Related]
9. Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growth.
Bohlen H; Thielemanns K; Tesch H; Engert A; Wolf HJ; van Camp B; Urbain J; Diehl V
Cytokines Mol Ther; 1996 Dec; 2(4):231-8. PubMed ID: 9384709
[TBL] [Abstract][Full Text] [Related]
10. CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice.
Saha A; Baral RN; Chatterjee SK; Mohanty K; Pal S; Foon KA; Primus FJ; Krieg AM; Weiner GJ; Bhattacharya-Chatterjee M
Cancer Immunol Immunother; 2006 May; 55(5):515-27. PubMed ID: 16044253
[TBL] [Abstract][Full Text] [Related]
11. [Immuno-therapeutic study of anti-idiotype minibody (single chain Fv-CH3) on ovarian carcinoma bearing mice].
Li Y; Chang XH; Cui H; Yang WL; Feng J; Wei LH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):451-6. PubMed ID: 12974094
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.
Foon KA; Sen G; Hutchins L; Kashala OL; Baral R; Banerjee M; Chakraborty M; Garrison J; Reisfeld RA; Bhattacharya-Chatterjee M
Clin Cancer Res; 1998 May; 4(5):1117-24. PubMed ID: 9607568
[TBL] [Abstract][Full Text] [Related]
13. A clinical trial of active immunotherapy with anti-idiotypic vaccine in nasopharyngeal carcinoma patients.
Li G; Xie L; Zhou G; Fu H; Zhou J; Sun Q
Chin Med J (Engl); 2002 Apr; 115(4):567-70. PubMed ID: 12133300
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
Li G; Hu J; Zhou G; Zhu J; Sun Q
Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392
[TBL] [Abstract][Full Text] [Related]
15. Role of T-cell subsets in the bispecific antibody (anti-idiotype x anti-CD3) treatment of the BCL1 lymphoma.
Demanet C; Brissinck J; Leo O; Moser M; Thielemans K
Cancer Res; 1994 Jun; 54(11):2973-8. PubMed ID: 8187084
[TBL] [Abstract][Full Text] [Related]
16. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M
Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590
[TBL] [Abstract][Full Text] [Related]
17. Immunological responses to the tumor-associated antigen CA125 in patients with advanced ovarian cancer induced by the murine monoclonal anti-idiotype vaccine ACA125.
Wagner U; Schlebusch H; Köhler S; Schmolling J; Grünn U; Krebs D
Hybridoma; 1997 Feb; 16(1):33-40. PubMed ID: 9085126
[TBL] [Abstract][Full Text] [Related]
18. Construction and selection of human anti-idiotypic antibody single chain variable fragments or CDR3 fragments of nasopharyngeal carcinoma.
He X; Li G; Zhu J
J Exp Clin Cancer Res; 2004 Dec; 23(4):607-15. PubMed ID: 15743031
[TBL] [Abstract][Full Text] [Related]
19. Active immunotherapy with anti-idiotypic antibody for patients with nasopharyngeal carcinoma (NPC).
Li G; Xie L; Zhou G; Zhu J; Hu J; Sun Q
Cancer Biother Radiopharm; 2002 Dec; 17(6):673-9. PubMed ID: 12537671
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of subcutaneous growth of Ehrlich ascites carcinoma (EAC) tumor by post-immunization with EAC-cell gangliosides and its anti-idiotype antibody in relation to tumor angiogenesis, apoptosis, cell cycle and infiltration of CD4+, CD8+ lymphocytes, NK cells, suppressor cells and APC-cells in tumor.
Mondal B; Saha S
Indian J Exp Biol; 2011 Aug; 49(8):574-84. PubMed ID: 21870425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
